Sun Pharma signs Definitive Agreement to Acquire Organon
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
BNP Paribas Exane Downgrades Organon & Co. (OGN) to Neutral Post Acquisition
April 28, 2026 6:17 AM EDTBNP Paribas Exane analyst Navaan Ty downgraded Organon & Co. (NYSE: OGN) from Outperform to Neutral.
For an analyst ratings summary and ratings history on Organon & Co. click here. For more ratings news on Organon & Co. click here.
Shares of Organon & Co. closed at $13.16 yesterday.
... More